Aveanna Healthcare Holdings Inc Dossier - Source-backed chat

Aveanna Healthcare Holdings Inc

AVAHNASDAQ

SectorHealth Care

IndustryMedical Care Facilities

Beta (adjusted)1.62

Intrinsic Value $27.89median of 5 methods · middle span $5-$34based on filings through 4 Jul 2026

Market Price $12.41Price as of 30 Sep 2026

Significantly undervaluedIntrinsic value is 125% above the market price

−50% · IV below pricenear fair value ±15%IV above price · +50%

marker beyond scale (+125%)

Data confidence Sign in to view data confidence

Market Cap $2.7B

Enterprise Value $3.9B

Shares Outstanding 231.7M diluted

Moat Rating Wide

Next Earnings Date5 Nov 2026

All prices and values are periodic snapshots, not live quotes. Source dates are shown for reference.

Thesis

Street consensus, scenarios, merits, risks, and invalidation triggers

AI-assisted

Thesis Summary

Aveanna Healthcare Holdings, Inc. (AVAH) is successfully executing its Strategic Transformation, shifting its business mix toward high-margin preferred payer contracts and expanding its specialized pediatric footprint. The recent $175.5 million acquisition of Family First Homecare significantly enhances its density in key markets like Florida and has led management to raise full-year 2026 revenue guidance to $2.63–$2.65 billion. Operational turnarounds, driven by robust volume growth in Private Duty Services (PDS) and AI-enabled administrative efficiencies, are driving substantial margin expansion and cash flow generation, making the stock highly attractive at current valuation levels.

This section is the 12-month view: analyst targets and the probability-weighted scenarios built from them. The intrinsic value at the top of this page answers a different question: what the business is worth today.

Street view · analyst 12-month targets10 analysts · as of 18 Aug 2026

Low · most bearish analyst$8.00

Mean target$12.35

High · most bullish analyst$16.00

Street targets sit below today's price; our intrinsic value sits above it. Different horizons, different questions.

Our research · scenarios, merits, risks, and invalidation triggersResearch as of 18 Sep 2026

Scenarios · 12-month scenario targetsAnchored at research date

Bear CaseDownside scenario

$8.00

Severe nurse shortages and wage inflation outpace state reimbursement rate updates, compressing PDS margins. Restrictive federal or state Medicaid reforms limit funding, while integration delays or higher interest rates on variable debt pressure free cash flow, stalling deleveraging efforts.

Base CaseCentral scenario

$12.35

Matches the consensus mean

Steady execution of the preferred payer strategy, maintaining PDS volume growth and keeping HHH episodic mix above 75%. Family First Homecare contributes $70 million in revenue for FY 2026, aligning with updated guidance of $2.63–$2.65 billion. Modest wage inflation is successfully offset by rate improvements, leading to stable margin expansion and deleveraging toward 4.4x debt-to-EBITDA.

Bull CaseUpside scenario

$16.00

Accelerated transition to preferred payer contracts (exceeding 80% of MCO volumes) combined with rapid integration of Family First Homecare and Thrive. Strong state-level Medicaid rate increases offset nurse wage inflation, while AI-driven back-office automation drives SG&A leverage, pushing Adjusted EBITDA margins toward 14% and unlocking significant free cash flow for debt paydown.

Scenarios are anchored to street consensus at the research date, with our probabilities and rationale.

Key Investment Merits

Strong top-line momentum with raised FY 2026 revenue guidance of $2.63–$2.65 billion following the Family First Homecare acquisition.
Successful execution of the preferred payer strategy, driving higher revenue per hour and improving caregiver recruitment and retention.
Substantial operational turnaround, with Q1 2026 net income surging to $41.7 million and Adjusted EBITDA rising 25.2% to $84.4 million.
Fragmented industry landscape provides ample opportunities for highly accretive, pediatric-focused M&A.

Key Investment Risks

High exposure to government-funded programs, making the company vulnerable to regulatory changes and Medicaid/Medicare reimbursement rate cuts.
Persistent labor shortages and wage inflation for skilled nurses and clinical staff.
Significant debt load ($1.49 billion of variable rate debt) exposes the company to interest rate fluctuations, though partially mitigated by swaps and caps.

Thesis Invalidation Triggers

A systemic reduction in state Medicaid reimbursement rates for private duty nursing.
Failure to integrate the Family First Homecare acquisition, resulting in goodwill impairment or operational disruption.
A sharp increase in caregiver turnover or wage inflation that cannot be offset by payer rate increases, leading to sequential margin contraction.

All scenarios are estimates and subject to change. Past performance is not indicative of future results.

Quality Pillars Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Explore this dossier

ValuationIntrinsic value, the six-method breakdown, peer medians, and your assumptions sandbox.Financial SnapshotRevenue, profitability, returns, balance sheet, dividends, and the filing-level detail.Qualitative AnalysisBusiness overview, strategic initiatives, and mergers, acquisitions & partnerships.Outlook & Key DatesForward estimates, reporting calendar, and the monitoring framework.